Wednesday, April 15, 2015

Danger and/or uselessness and/or reduced benefit

Contact | Alessandro Doria | Harvard T.H. Chan School of ...

www.hsph.harvard.edu/alessa...
Harvard T.H. Chan School of Public Health
Section on Genetics and Epidemiology, Joslin Diabetes Center Room 445A. Boston, MA 02215. Phone: 617.732.2406. alessandro.doria@joslin.harvard.edu ...you can modify kidney function in type 1 diabetes with BCG



Michael Mauer, MD - Department of Pediatrics - University of ...

www.peds.umn.edu/nephrology/.../michael-mau...
University of Minnesota
Apr 22, 2013 - Contact Info. Email mauer002@umn.edu. Phone (612) 626-2720 (612) 626-2922. Fax (612) 626-2791. Office Address Pediatric Nephrology
The below research should compare BCG with allopurinol and not Allopurinol with a placebo

Research such as the below does not address the immune system and/or take a wholistic view of the disease process.  There is much bad science and/art as there are auto mechanics who swap parts without a procedural approach.

Write to the below authors and help educate them and test the openness and flexibility of their minds.


Results: 2

1.
Maahs DM, Caramori L, Cherney DZ, Galecki AT, Gao C, Jalal D, Perkins BA, Pop-Busui R, Rossing P, Mauer M, Doria A; PERL Consortium.
Curr Diab Rep. 2013 Aug;13(4):550-9. doi: 10.1007/s11892-013-0381-0. Review.
2.
Doria A, Niewczas MA, Fiorina P.
Semin Nephrol. 2012 Sep;32(5):437-44. doi: 10.1016/j.semnephrol.2012.07.006.
PMID:
23062984
Free PMC Article

No comments:

Post a Comment